Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 1
2009 3
2010 2
2011 3
2012 2
2013 4
2014 5
2015 4
2016 7
2017 5
2018 2
2019 4
2020 4
2021 2
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Young Adult Secondary Cancer After Proton Beam Therapy: A Case Study.
Yamamori A, Murayama S, Takahashi I, Akaihata M, Kakuda Y, Sugino T, Aramaki T, Onoe T, Takahashi Y, Ishida Y. Yamamori A, et al. Among authors: murayama s. Adv Radiat Oncol. 2023 Jul 1;9(1):101307. doi: 10.1016/j.adro.2023.101307. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260212 Free PMC article. No abstract available.
Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M, Yasui K, Oota N, Ogawa H, Onoe T, Maki S, Ito Y, Hayashi K, Asakura H, Murayama S, Mitsuya K, Deguchi S, Nakamura K, Hayashi N, Nishimura T, Harada H. Hirata M, et al. Among authors: murayama s. Radiat Oncol. 2023 Mar 3;18(1):45. doi: 10.1186/s13014-023-02206-7. Radiat Oncol. 2023. PMID: 36869325 Free PMC article. No abstract available.
Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M, Yasui K, Oota N, Ogawa H, Onoe T, Maki S, Ito Y, Hayashi K, Asakura H, Murayama S, Mitsuya K, Deguchi S, Nakamura K, Hayashi N, Nishimura T, Harada H. Hirata M, et al. Among authors: murayama s. Radiat Oncol. 2022 Dec 28;17(1):213. doi: 10.1186/s13014-022-02185-1. Radiat Oncol. 2022. PMID: 36578021 Free PMC article.
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence.
Yasui K, Kondou R, Miyata H, Iizuka A, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Muramatsu K, Sugino T, Yamaguchi K, Ogawa H, Onoe T, Harada H, Asakura H, Murayama S, Nishimura T, Goto S, Okada S, Mukaigawa T, Hamauchi S, Yokota T, Onozawa Y, Akiyama Y. Yasui K, et al. Among authors: murayama s. Anticancer Res. 2022 Sep;42(9):4417-4428. doi: 10.21873/anticanres.15942. Anticancer Res. 2022. PMID: 36039416
Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906.
Nozaki M, Kagami Y, Takahashi M, Machida R, Sekino Y, Shibata T, Ito Y, Nishimura Y, Teshima T, Ushijima H, Nagata Y, Matsumoto Y, Akimoto T, Takahashi K, Murayama S, Uno T, Tsujino K, Hamamoto Y, Nakagawa K, Kodaira T, Hiraoka M; Radiation Therapy Study Group, Japan Clinical Oncology Group. Nozaki M, et al. Among authors: murayama s. Breast Cancer. 2022 Nov;29(6):1042-1049. doi: 10.1007/s12282-022-01384-8. Epub 2022 Jul 21. Breast Cancer. 2022. PMID: 35861936
53 results